H. Pylori Eradication After Peptic Ulcer Stabilization

Timing of Eradication Therapy

• The American Gastroenterological Association recommends starting eradication treatment as soon as oral feeding is reintroduced after stabilization of a bleeding peptic ulcer, rather than waiting for complete ulcer healing or hospital discharge 1
• Delaying treatment until after discharge leads to reduced compliance and loss to follow-up, making immediate initiation the most cost-effective strategy 1
• H. pylori eradication has no effect on early rebleeding rates after endoscopic hemostasis, so there is no benefit to waiting 1

Rationale for Eradication

• A meta-analysis demonstrated that H. pylori eradication is significantly more effective than PPI therapy alone in preventing rebleeding from peptic ulcer disease, according to the American College of Gastroenterology 2
• Successful eradication achieves ulcer healing rates exceeding 90% and essentially cures peptic ulcer disease by preventing recurrences, as recommended by the European Helicobacter Study Group 1

Recommended Treatment Regimens

• The American College of Gastroenterology recommends first-line triple therapy consisting of PPI, amoxicillin, and clarithromycin for 14 days 1
• In areas with high clarithromycin resistance, the European Helicobacter Study Group suggests considering sequential therapy or bismuth-based quadruple therapy 1

Post-Eradication PPI Management

• The American Gastroenterological Association recommends against prolonged PPI therapy after successful H. pylori eradication in patients with uncomplicated duodenal ulcers 1
• The European Helicobacter Study Group suggests continuing PPI until complete healing is achieved and eradication is confirmed in patients with gastric ulcers 1

Confirmation of Eradication

• The American College of Gastroenterology recommends confirming eradication in all patients with bleeding peptic ulcers, using tests such as urea breath test or monoclonal stool antigen test at least 4 weeks after completion of therapy 2, 1

Critical Pitfalls to Avoid

• Diagnostic tests for H. pylori show 25-55% false-negative rates during acute upper GI bleeding, according to the American Gastroenterological Association 2
• The European Helicobacter Study Group recommends repeat testing at follow-up if initial tests are negative during the acute bleeding episode 2

Management of Bleeding Peptic Ulcer Disease

Acute Management Phase

• The American College of Gastroenterology recommends initiating high-dose intravenous PPI therapy immediately in an elderly patient with bleeding peptic ulcer disease who is H. pylori-positive, to reduce rebleeding risk and facilitate endoscopic visualization 3, 4
• Assess surgical risk using APACHE II score, as mortality after urgent surgery correlates directly with preoperative physiologic status, and involve consultant surgeon and anesthesiologist early in high-risk cases 5, 6
• Perform urgent endoscopy for diagnosis, risk stratification, and therapeutic intervention when indicated, and obtain gastric biopsies during endoscopy for H. pylori testing if not previously confirmed 3, 4
• Apply endoscopic hemostasis techniques for actively bleeding ulcers or those with high-risk stigmata 3

H. pylori Management

• Confirm H. pylori status in all bleeding peptic ulcer patients, as eradication dramatically reduces rebleeding risk, using urea breath test or stool antigen testing for non-invasive confirmation if endoscopic biopsy was not obtained 3, 4
• Start standard triple therapy after 72-96 hours of intravenous PPI administration and continue for 14 days total, consisting of PPI, amoxicillin, and clarithromycin 3, 4, 7
• Successful H. pylori eradication reduces rebleeding rates from 26% to near zero in patients with H. pylori-associated bleeding ulcers 3, 4

Post-Acute Management

• Discontinue NSAIDs and aspirin immediately if medically feasible, and consider COX-2 selective inhibitors as an alternative, though these still require PPI co-therapy in patients with previous bleeding 5, 6
• Perform repeat endoscopy at 6 weeks post-discharge to confirm healing and exclude malignancy for gastric ulcers, continuing PPI therapy until that point 5, 6, 8
• Confirm H. pylori eradication at least 4 weeks after completing therapy in all complicated peptic ulcer cases 7

Special Considerations in Elderly Patients

• Avoid extensive surgical procedures in frail elderly patients when minimal intervention can achieve hemostasis, and do not skip H. pylori testing and eradication in elderly patients—the clinical benefit is proven and substantial 5, 6
• Do not delay starting triple therapy beyond 96 hours of IV PPI administration, as this is the optimal window 3, 4

H. Pylori Eradication Confirmation and Management

Testing Methods and Timing

• Testing should be performed off PPI therapy (ideally 2 weeks after stopping) to maximize test accuracy, as PPIs can suppress H. pylori and cause false-negative results, according to the World Journal of Emergency Surgery 9
• Urea breath test (UBT) is the preferred non-invasive method with 88-95% sensitivity and 95-100% specificity, as recommended by the World Journal of Emergency Surgery 9
• Stool antigen testing is an acceptable alternative with 94% sensitivity and 92% specificity, as stated by the World Journal of Emergency Surgery 9
• Avoid serologic antibody testing for confirmation, as antibodies remain positive for months to years after successful eradication and cannot distinguish active from past infection, according to the World Journal of Emergency Surgery 9

Management Based on Eradication Results

• If eradication fails, initiate second-line therapy with a different regimen (typically levofloxacin-amoxicillin triple therapy for 10 days), then retest 4 weeks after completing the second course, as recommended by the World Journal of Emergency Surgery 9

Additional Follow-Up Considerations

• For gastric ulcers specifically, perform repeat endoscopy at 6 weeks post-discharge to confirm ulcer healing and exclude malignancy, regardless of H. pylori status, as suggested by Gut 10
• For duodenal ulcers, endoscopic confirmation of healing is generally not necessary after successful H. pylori eradication, unless the patient needs to continue NSAIDs, according to Gut 10

Management of Peptic Ulcer with Gastrointestinal Bleeding – Evidence‑Based Recommendations

Pre‑Endoscopic Pharmacotherapy

• High‑dose intravenous proton‑pump inhibitor (PPI) administered before endoscopy (80 mg bolus) does not replace the need for urgent endoscopy and does not reduce mortality or re‑bleeding rates; it should be given promptly while arranging endoscopy. 11

H. pylori Testing and Eradication

• During active upper‑GI bleeding, endoscopic biopsy testing for Helicobacter pylori yields a false‑negative rate of roughly 25‑55 %, necessitating repeat testing after the acute episode. 11

• Confirming successful H. pylori eradication lowers the risk of ulcer re‑bleeding from approximately 26‑62 % down to 0‑2 %, underscoring the importance of post‑treatment testing. 11

Critical Pitfalls to Avoid

• Proton‑pump inhibitor therapy must not be used as a substitute for urgent endoscopy in patients with active bleeding; definitive endoscopic evaluation and hemostasis remain essential. 11